FindTrial
Sign In

Development of a Decision-Making Model for Intravenous Thrombolysis and Prognostic Analysis in Acute Ischemic Stroke in Beijing

Development of a Decision-Making Model for Intravenous Thrombolysis and Prognostic Analysis in Acute Ischemic Stroke in Beijing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126912
Enrollment
Unknown
Registered
2026-06-18
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Interventions

Acute Ischemic Stroke Group:None

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for ischemic stroke stipulated in the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2023, with the corresponding code I63 in the International Classification of Diseases, 10th Revision (ICD-10). 2. Aged <= 120 years. 3. No restriction on gender.

Exclusion criteria

Exclusion criteria: 1.Cases where data fusion cannot be performed due to incomplete demographic information (e.g., gender, age, etc.).

Design outcomes

Primary

MeasureTime frame
All-cause Mortality in Patients with Acute Ischemic Stroke Undergoing Intravenous Thrombolysis;—

Secondary

MeasureTime frame
Relapse;Rehospitalization;—

Countries

China

Contacts

Public ContactZheng Long

Xuanwu Hospital Capital Medical University

longzheng@xwhosp.org+86 10 83198730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026